RecruitingPhase 2NCT07364747
Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial
Studying Radiation-induced disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Siriraj Hospital
- Principal Investigator
- Kanthong Thongyai, MasterSiriraj Hospital
- Intervention
- Acetyl cysteine(drug)
- Enrollment
- 40 target
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Bangkoknoi, Thailand
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07364747 on ClinicalTrials.govOther trials for Radiation-induced disorder
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07597083Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer SurvivorsBeni-Suef University
- RECRUITINGPHASE1, PHASE2NCT07269041Immune Tolerance Induction After Liver TransplantationUniversity of California, Los Angeles
- RECRUITINGPHASE2NCT07400328Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT PatientsThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE2NCT07029178Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and DermatitisShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGNANCT07510061Title: ICARUS - Psycho-physiological Profiling of Low and High Heat-resilient IndividualsUniversity of Thessaly
- RECRUITINGPHASE2, PHASE3NCT07131319SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLCSecond Affiliated Hospital of Nanchang University
- RECRUITINGPHASE1, PHASE2NCT06714253Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1RiboX Therapeutics Ltd.
- RECRUITINGNCT06443645Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-BCentre Paul Strauss